ARLINGTON, Va., September 7, 2016 -- The American Society for Radiation Oncology (ASTRO) announced today the press program for its 58th Annual Meeting, which includes multiple reports from phase III clinical trials, researchers from leading institutions in the U.S. and abroad, and examinations of a range of cancer types and patient populations. Researchers will share their findings in a series of briefings held on-site at the Boston Convention & Exhibition Center and webcast to registered press.
The news briefing schedule is as follows:
Meeting Overview & Report on ASTRO Initiatives
- Sunday, September 25, 2:45 p.m. - 3:15 p.m. ET
- Features David C. Beyer, MD, FASTRO, current President and incoming Chair of ASTRO
Refining Treatment Decisions
- Monday, September 26, 8:00 a.m. - 9:00 a.m. ET
- Features studies evaluating conventional versus accelerated treatment approaches for brain metastases, lung cancer and prostate cancer
Expanding Access to Care
- Monday, September 26, 10:30 a.m. - 11:30 a.m. ET
- Features studies on expanding care to overlooked or growing patient populations, including elderly patients, African Americans, developing countries and veterans
Advances in Prostate Cancer Care
- Tuesday, September 27, 8:00 a.m. - 9:00 a.m. ET
- Features large trials and multi-institution studies examining treatment advances in brachytherapy, teletherapy and biomarker subtyping for prostate cancer
Innovations in RT Delivery
- Tuesday, September 27, 1:30 p.m. - 2:30 p.m. ET
- Features reports of how new approaches to radiation therapy delivery impact disease control and quality of life for gynecologic, breast and pediatric brain cancers
Credentialed journalists from accredited news organizations are invited to attend and report on ASTRO's 58th Annual Meeting. More information on press policies, registration and briefing webcasts is available at http://www.
All news briefings will be available live on-site in Boston and via webcast for registered press, with audio recordings, slides and photos posted on the ASTRO website after each briefing. Embargoed news releases will be distributed to registered press in advance of the news briefings.
The 2016 ASTRO Annual Meeting, to be held September 25-28, 2016, at the Boston Convention and Exhibition Center, is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. The meeting will feature a record number of abstracts, scientific and educational presentations on radiation oncology clinical trials and research, and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization and a top safety executive from Delta Air Lines. Led by ASTRO President David C. Beyer, MD, FASTRO, the 2016 meeting is organized around the theme, "Enhancing Value, Improving Outcomes," echoing growing calls from policy makers, physicians and patients for value-based health care. Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.
ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologists, physicists, radiation therapists, dosimetrists and other health care professionals who specialize in treating patients with radiation therapies. As the leading organization in radiation oncology, the Society is dedicated to improving patient care through professional education and training, support for clinical practice and health policy standards, advancement of science and research, and advocacy. ASTRO publishes three medical journals, International Journal of Radiation Oncology * Biology * Physics, Practical Radiation Oncology and Advances in Radiation Oncology; developed and maintains an extensive patient website, RT Answers (http://www.